$SVRA Cashflow Statement | Understand Stock

$SVRA

$4.86 +$0.34 (7.52%) Close

$SVRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Reduction in the carrying value of right-of-use assets
Non-cash interest income
Foreign currency gain (loss)
Foreign currency loss
Amortization of debt issuance costs
Loss on extinguishment of debt
Accretion on discount to short-term investments
Stock-based compensation
Changes in operating assets and liabilities:
Prepaid expenses and other current assets
Non-current assets
Accounts payable and accrued expenses and other current liabilities
Long-term liabilities

Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Purchase of available-for-sale securities, net
Maturity of available-for-sale securities
Sale of available-for-sale securities, net
Net cash used in investing activities
Cash flows from financing activities:
Repurchase of outstanding pre-funded warrants
Repayment of long-term debt
Proceeds from long-term debt, net
Issuance of common stock and pre-funded warrants in public offering, net of offering costs
Issuance of common stock upon exercise of warrants, net
Issuance of common stock and pre-funded warrants in underwritten offering, net of offering costs
Issuance of common stock issued in underwritten offering, net of offering costs
Issuance of common stock upon exercise of prefunded warrants
Issuance of common stock upon at the market offerings, net
Proceeds from exercise of stock options
Reimbursement of commissions from the prior issuance of common stock upon at the market sales, net
Repurchase of shares for minimum tax withholdings
Net cash provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents beginning of period
Cash and cash equivalents end of period
Supplemental disclosure of cash flow information:
Cash paid for interest

Comments